Cite

HARVARD Citation

    Boonstra, P. et al. (n.d.). A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T‐cell lymphomas. American journal of hematology. 92 (12), pp. 1287-1294. [Online]. 
  
Back to record